Effect of short-term treatment with levosimendan on oxidative stress in renal tissues of rats
- 21 June 2012
- journal article
- Published by SAGE Publications in Toxicology and Industrial Health
- Vol. 30 (1) , 47-51
Abstract
The aim of this study is to evaluate the influences of short-term treatment with levosimendan (chemical formula: C14H12N6O) on oxidative stress and some trace element levels in renal tissues of healthy rats. A total of 20 male Wistar-albino rats were randomly divided into two groups, each consisting of 10 rats. Animals in the first group were not treated with levosimendan and served as control. Animals in the second group were injected intraperitoneally with 12 µg/kg levosimendan and served as levosimendan group. Animals in both the groups were killed 3 days after the treatment, and their kidneys were harvested for the determination of tissue oxidant/antioxidant statues and trace element levels in renal tissues. The tissue malondialdehyde level was significantly ( p < 0.001) lower in levosimendan group than in controls. The protective enzyme activities such as superoxide dismutase, catalase, and glutathione peroxidase and antioxidant glutathione level were significantly ( p < 0.001) higher in levosimendan group than in controls. It was concluded that levosimendan reduced oxidative stress by avoiding lipid peroxidation and production of reactive oxygen species, and overactivating and/or increasing the protective antioxidant enzyme levels in renal tissues of rats. It is supposed that this experimental study provides beneficial data for clinicians in the management of renal tissue damage related to obstruction and/or ischemia.Keywords
This publication has 17 references indexed in Scilit:
- The effects of rosiglitazone on oxidative stress and lipid profile in left ventricular muscles of diabetic ratsCell Biochemistry and Function, 2008
- Levosimendan Improves Renal Function in Patients With Advanced Chronic Heart Failure Awaiting Cardiac TransplantationJournal of Cardiac Failure, 2007
- Levosimendan protects against experimental endotoxemic acute renal failureAmerican Journal of Physiology-Renal Physiology, 2006
- Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failureThe American Journal of Cardiology, 2004
- Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trialThe Lancet, 2002
- Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis “Thioredoxin reductase—interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid” by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4.Free Radical Biology and Medicine, 2001
- Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic MiceJournal of Biological Chemistry, 1996
- Effect of pentoxifylline on tissue injury and platelet-activating factor production during ischemia-reperfusion injuryJournal of Vascular Surgery, 1995
- Lipid peroxidation during myocardial ischaemia induced by pacing.Heart, 1990
- Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagentAnalytical Biochemistry, 1968